GYZ-85739-59427
2 vaccinations
9 coded responses
14 check-ins
9 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 606 / IL
- Registered
- 2021-04-02
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-02
Registered in v-safe
-
2021-04-02
Dose 1 — Pfizer-BioNTech
-
2021-04-03
Survey response — days 1–6 daily, dose 1MedDRA: Maternal exposure during breast feeding — Feeling: Good · Site: Pain · Headache, Fatigue or tirednessFree text: Breastfeeding - 8 weeks postpartumMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-03
Survey response — day 0, dose 1MedDRA: Breast feeding — Feeling: Good · Site: PainFree text: Currently breastfeeding - 8 weeks postpartumMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-05
Survey response — days 1–6 daily, dose 1MedDRA: Breast feeding — Feeling: GoodFree text: 8 weeks postpartum - currently breastfeedingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-06
Survey response — days 1–6 daily, dose 1MedDRA: Breast feeding — Feeling: GoodFree text: 9 weeks postpartum - currently breastfeedingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-08
Survey response — days 1–6 daily, dose 1MedDRA: Breast feeding, Postpartum state — Feeling: GoodFree text: 9weeks postpartum, currently breastfeedingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-09
Survey response — day 7, dose 1MedDRA: Breast feeding, Postpartum state — Feeling: GoodFree text: 9 weeks postpartum. Currently breastfeeding.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-16
-
2021-04-23
Dose 2 — Pfizer-BioNTech
-
2021-04-30
Survey response — day 7, dose 2MedDRA: Breast feeding — Feeling: GoodFree text: 2.5 months postpartum, breastfeedingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-07
- 2021-05-14
-
2021-05-23
Survey response — day 28, dose 2MedDRA: Migraine — Feeling: Good · Be unable to do your normal daily activitiesFree text: MigraineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-28
- 2021-06-07
-
2022-04-23
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to do your normal daily activitiesFree text: Covid+ Feb.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-02 | Pfizer-BioNTech | |
| 2 | 2021-04-23 | Pfizer-BioNTech |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Breastfeeding - 8 weeks postpartum
Release 6 — day 0, dose 1
Systemic reaction (other): Currently breastfeeding - 8 weeks postpartum
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): 8 weeks postpartum - currently breastfeeding
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): 9 weeks postpartum - currently breastfeeding
Systemic reaction (other): 9weeks postpartum, currently breastfeeding
Release 7 — day 7, dose 1
Systemic reaction (other): 9 weeks postpartum. Currently breastfeeding.
Release 8 — day 7, dose 2
Systemic reaction (other): 2.5 months postpartum, breastfeeding
Release 8 — day 28, dose 2
Symptoms: Migraine
Release 11 — 12 months, dose 2
Symptoms: Covid+ Feb.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SRO | Breast feeding | ✓ | ✓ | ✓ |
| SRO | Maternal exposure during breast feeding | ✓ | ✓ | ✓ |
| SRO | Postpartum state | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release